U.S. markets open in 1 hour 4 minutes

ConvaTec Group PLC (CTEC.L)

LSE - LSE Precio retrasado. Divisa en GBp (0.01 GBP).
Añadir a la lista de seguimiento
254.20-0.40 (-0.16%)
A partir del 01:10PM BST. Mercado abierto.

ConvaTec Group PLC

20 Eastbourne Terrace
7th Floor
London W2 6LG
United Kingdom

https://www.convatecgroup.com

Sector(es)Healthcare
IndustriaMedical Instruments & Supplies
Empleados a tiempo completo10,136

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Karim BitarCEO & Director2.97MN/D1965
Mr. Jonathan Peter MasonGroup CFO & Director1.59MN/D1964
Mr. John HallerExecutive VP and Chief Quality & Operations OfficerN/DN/DN/D
Dr. Divakar Ramakrishnan Ph.D.Executive VP, Chief Technology Officer and Head of Research & DevelopmentN/DN/DN/D
Ms. Kate PostansVice President of Investor Relations & Corporate CommunicationsN/DN/DN/D
Ms. Evelyn Douglas J.D.Executive VP, Chief of Corporate Strategy & Business Development and General CounselN/DN/DN/D
Ms. Moyra WithycombeInterim Chief People OfficerN/DN/DN/D
Ms. Kjersti Grimsrud Biotechnology, M.Sc.President & COO of Infusion CareN/DN/D1961
Mr. David ShepherdPresident & COO of Global Advanced Wound CareN/DN/DN/D
Mr. Seth R. SegelPresident and COO of Continence Care & Home Services GroupN/DN/D1969
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en GBp.

Descripción

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Gestión corporativa

La calificación ISS Governance QuickScore de ConvaTec Group PLC a partir del 1 de mayo de 2024 es 2. Las puntuaciones principales son Auditoría: 3; Junta: 3; Derechos del accionista: 1; Compensación: 1.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.